These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15777579)

  • 1. [Macrophagic myofasciitis: a new disease's paradigm?].
    Papo T
    Rev Med Interne; 2005 Mar; 26(3):175-8. PubMed ID: 15777579
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophagic myofasciitis in children is a localized reaction to vaccination.
    Lach B; Cupler EJ
    J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophagic myofasciitis: an infantile Italian case.
    Di Muzio A; Capasso M; Verrotti A; Trotta D; Lupo S; Pappalepore N; Manzoli C; Chiarelli F; Uncini A
    Neuromuscul Disord; 2004 Feb; 14(2):175-7. PubMed ID: 14733966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants?
    Guis S; Mattei JP; Nicoli F; Pellissier JF; Kaplanski G; Figarella-Branger D; Manez GC; Antipoff GM; Roudier J
    Arthritis Rheum; 2002 Oct; 47(5):543-5. PubMed ID: 12382305
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments about the editorial by Thomas Papo entitled "Macrophagic myofasciitis: focal or systemic?".
    Guis S; Roudier J
    Joint Bone Spine; 2004 Mar; 71(2):164; author rely 164-5. PubMed ID: 15050207
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial macrophagic myofasciitis.
    Amoura Z; Costedoat N; Maisonobe T; Godeau P; Piette JC
    Ann Rheum Dis; 2000 Nov; 59(11):927-8. PubMed ID: 11203423
    [No Abstract]   [Full Text] [Related]  

  • 7. Childhood macrophagic myofasciitis-consanguinity and clinicopathological features.
    Nevo Y; Kutai M; Jossiphov J; Livne A; Neeman Z; Arad T; Popovitz-Biro R; Atsmon J; Shapira Y; Soffer D
    Neuromuscul Disord; 2004 Apr; 14(4):246-52. PubMed ID: 15019702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background.
    Authier FJ; Sauvat S; Christov C; Chariot P; Raisbeck G; Poron MF; Yiou F; Gherardi R
    Neuromuscul Disord; 2006 May; 16(5):347-52. PubMed ID: 16616846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphea profunda in a young infant after hepatitis B vaccination.
    Benmously Mlika R; Kenani N; Badri T; Hammami H; Hichri J; Haouet S; Mokhtar I; Fenniche S
    J Am Acad Dermatol; 2010 Dec; 63(6):1111-2. PubMed ID: 21093674
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
    Gherardi RK
    Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of hepatitis B vaccine regimens in adults with HIV-1.
    Bélec L; Authier FJ; Gherardi RK
    JAMA; 2011 Jul; 306(2):156; author reply 156-7. PubMed ID: 21750288
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophagic myofasciitis associated with vaccine-derived aluminium.
    Shingde M; Hughes J; Boadle R; Wills EJ; Pamphlett R
    Med J Aust; 2005 Aug; 183(3):145-6. PubMed ID: 16053418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex regional pain syndrome after hepatitis B vaccine.
    Jastaniah WA; Dobson S; Lugsdin JG; Petty RE
    J Pediatr; 2003 Dec; 143(6):802-4. PubMed ID: 14657832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patient's information. Vaccination against hepatitis A and B in chronic liver diseases].
    Moreira VF; Garrido E
    Rev Esp Enferm Dig; 2011 Jan; 103(1):42. PubMed ID: 21341939
    [No Abstract]   [Full Text] [Related]  

  • 15. Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis.
    Preusse C; Goebel HH; Pehl D; Rinnenthal JL; Kley RA; Allenbach Y; Heppner FL; Vorgerd M; Authier FJ; Gherardi R; Stenzel W
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):952-63. PubMed ID: 25711697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of HB vaccine].
    Sodeyama T; Kobayashi M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():216-21. PubMed ID: 15453318
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
    Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
    JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The reactogenicity of Heberbiovac-HB vaccine at different doses].
    Díaz González M; Navia Molina O; Bravo González JR; Pedroso Flaquet P; Urbino López A
    Rev Cubana Med Trop; 1995; 47(1):65-70. PubMed ID: 9805071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and 31PMR spectroscopy investigations of muscle function disclose no abnormality in macrophagic myofasciitis.
    Guis S; Mattei JP; Pellissier JF; Nicoli F; Figarella-Branger D; Le Fur Y; Kaplanski G; Pelletier J; Harle JR; Cozzone PJ; Bendahan D
    J Rheumatol; 2004 Nov; 31(11):2313-4. PubMed ID: 15517654
    [No Abstract]   [Full Text] [Related]  

  • 20. [HBsAg expression, anti-HBs induction and pathological observation in the mice inoculated with DNA vaccine against hepatitis B].
    Zhao L; Qin S; Tang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):51-3. PubMed ID: 12759954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.